skip to main content

Apixaban dose review — GPhC CRA MCQ

Instant feedback + full explanation. One question, done properly.

ModerateRenal and Hepatic ImpairmentApixaban dose reviewGPhC CRA

An 84-year-old patient on apixaban has new renal impairment and low body weight documented. They asks for a repeat supply. What monitoring is required?

Educational content. Not a substitute for clinical judgement or local policy.

Reveal the answer and explanation

Correct answer: E — Check renal function, age and weight criteria before supply

DOAC dosing depends on indication and patient factors including renal function, age and weight. Changes can require dose review to balance stroke and bleeding risk. In this scenario, the correct option is check renal function, age and weight criteria before supply. The other options are plausible but do not address the key clinical, legal or safety issue as directly. This aligns with UK pharmacy practice guidance cited in the reference field.

Reference: BNF